ARCHIVES

DCCP Board Approves Concepts Of $2.6 Million In New Competing Projects, $1.2 Million In Recompetitions

This article is from The Cancer Letter archive.

Vol. 07 No. 39 | September 25, 1981

Download PDF Visit The Full Archive

Related Articles

Clinical Trial System Inefficient, UPCI Director Tells Senate

June 7, 2002

FDA News: FDA Taking Comments on “First Generic” ANDA Process

November 21, 2014

ACCC Members Hear How Community Cancer Programs Are Developed

February 11, 1977

Suitable Mechanism, Funding Source Were Issues In diet FIT

December 15, 1989

News Analysis: Generic Drug Industry’s Efforts to Eliminate Shortages Raises Antitrust Law Questions

April 27, 2012

FDA Approved More Than 50 New Indications For Cancer In 32 Months, Analysis Finds

February 19, 2010